HOUSTON, Sept. 14, 2023 /PRNewswire/ -- FibroBiologics, a clinical-stage biotechnology company focused on developing potential therapies and cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Pete O'Heeron, Founder and CEO, and Hamid Khoja Ph.D., Chief Scientific Officer, will make company presentations at the upcoming Life Science Intelligence (LSI) Europe '23 Emerging Medical Technologies Summit on September 18-22, 2023; and meeting of cells and genes on the table from October 10 to 12, 2023.
Details of upcoming conference presentations are as follows:
LSI Europe '23 Emerging MedTech Summit (Barcelona, 18-22 de septiembre)
"Our presence at these conferences illustrates our commitment to remaining at the forefront of developing innovative approaches to the treatment of chronic diseases, sharing knowledge and fostering collaborations with academia and the biotechnology community that will drive progress and shape the future," stated Pete O'Heeron. "These two conferences give us the opportunity to showcase FibroBiologics' recent advancements and achievements in advancing our fibroblast cell-based treatments."
About FibroBiologics Houston-based FibroBiologics is a cell therapy and regenerative medicine company developing a pipeline of potential treatments and cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds over 150 patents/issued patents pending in the United States and internationally in various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, organ involution reversal, and cancer. FibroBiologics represents the next generation of medical advances in cell therapy. For more information, visit www.FibroBiologics.com.
General inquiries: firstname.lastname@example.org
Investor Relations:Nic Johnson or Harrison Seidner, Ph.D.Russo Partners(646) 942-5599fibrobiologicsIR@russopr.com
Media Contact:Liz PhillipsRusso Partners(347) 956-7697Elizabeth.email@example.com
Photo - https://mma.prnewswire.com/media/1588787...Logo - https://mma.prnewswire.com/media/1588786...
View original content: https://www.prnewswire.com/news-releases/fibrobiologics-proporcionara-informacion-actualizada-sobre-la-empresa-en-las-proximas-conferencias-301927807.html